Over 2,000 real rulings β analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA case AUTH/3120/11/18 (Director v Shire) about clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
PMCPA case AUTH/3077/9/18 (Otsuka UK) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016). No…
A patient received a survey invite from a market research agency after registering on a Rebif support site. She alleged improper sharing…
Anonymous neurologist alleged Zonegran promotion implied use in overweight epileptics. PMCPA found the detail aid misleading on weight effects, exaggerating properties and…
A pharmacist challenged GSK claims that Seretide was βpriced competitivelyβ and could help NHS QIPP targets. The PMCPA Panel found both claims…
Vifor left two website press releases live containing a Ferinject claim previously ruled misleading about hypersensitivity. PMCPA found a breach of undertaking…
GSK alleged Chiesi promoted Fostair for COPD before UK authorisation via an ATS symposium and a sponsored journal. PMCPA found off-label promotion,…
Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast (5-star venue, golf, gala dinner). For Recordati, PMCPA found…
Anonymous complaint about Roche buying drinks in a hotel bar during BSH 2013. Panel found one instance (Sunday pre-conference bar drinks plus…
A Picato journal ad using βThe revolutionary, shortest durationβ¦β plus a high-speed train implied broader indication and faster effect. PMCPA found breaches…
Sanofi invited HCPs to a Lyxumia Speaker Club and referenced Β£1,000 payment. Panel found no inducement/payment breach on the narrow allegation, but…
A GP alleged a Takeda-sponsored meeting speaker said Prostap injection route βdid not matterβ, implying off-licence promotion. Panel found evidence insufficient on…
A Circadin journal ad said βCurrent guidance statesβ¦β but the source was a BAP consensus statement, not NICE/AWMSG. The Panel found the…
MHRA referred a complaint that Nicoventures set pre-licence call rates for HDMs ahead of Vokeβs authorisation. Panel found advance budget notification was…
Sanofi Genzyme admitted inviting patient organisation members to BIA gala dinners (2014/2015) with significant hospitality and likely >Β£75 subsistence, without clear educational…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week β free.